PRNewsWire
30 Apr 2026, 23:42 UTC · 25w ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Compass Therapeutics, Inc. - CMPX
Verdict
Headline takes no side. We score CMPX −1.00 — strongly bearish.
- Expected · CMPX
−1.00strongly bearish
−1 bearish0bullish +1More negative than 96% of ticker scores this week
- Actual





